MOSSLEY & DUDLEY FIELDS MEDICAL PRACTICE — All Prescriptions & Medications — Page 2
Practice Code: M91029 | WALSALL, WS3 2TA
Showing results 51-100 of 526
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Propranolol hydrochloride | 601 | 50.8K | £1.6K | -43.7% ▼ |
| Gliclazide | 600 | 38.3K | £1.3K | -29.5% ▼ |
| Tamsulosin hydrochloride | 594 | 22.8K | £920 | -56.2% ▼ |
| Doxycycline hyclate | 588 | 6,706 | £660 | +14.7% ▲ |
| Zopiclone | 580 | 8,989 | £418 | +4.7% ▲ |
| Melatonin | 566 | 30.2K | £7.7K | +70.2% ▲ |
| Ibuprofen | 566 | 53.6K | £2.4K | +11.3% ▲ |
| Allopurinol | 555 | 28.4K | £620 | -46.2% ▼ |
| Carbocisteine | 519 | 90.6K | £2.5K | -2.8% ▼ |
| Montelukast | 512 | 16.2K | £756 | -25.2% ▼ |
| Alginic acid compound preparations | 484 | 227.5K | £2.8K | -17.4% ▼ |
| Hydrocortisone | 481 | 14.5K | £2.6K | +7.3% ▲ |
| Ferrous fumarate | 472 | 40.6K | £1.5K | -34.9% ▼ |
| Edoxaban | 450 | 15.1K | £25.1K | -35.8% ▼ |
| Empagliflozin | 442 | 14.0K | £17.4K | -29.4% ▼ |
| Isosorbide mononitrate | 430 | 15.6K | £2.4K | -34.9% ▼ |
| 423 | 945 | £31.9K | -22.4% ▼ | |
| Rosuvastatin calcium | 419 | 17.9K | £506 | -53.3% ▼ |
| Alogliptin | 415 | 17.6K | £15.9K | +63.6% ▲ |
| 409 | 5,202 | £2.9K | -38.4% ▼ | |
| Mebeverine hydrochloride | 405 | 32.0K | £1.3K | +30.4% ▲ |
| Aripiprazole | 396 | 10.6K | £1.8K | +55.6% ▲ |
| Indapamide | 385 | 16.2K | £844 | -55.4% ▼ |
| Sildenafil (Erectile Dysfunction) | 375 | 3,280 | £447 | -25.6% ▼ |
| Flucloxacillin sodium | 372 | 16.4K | £829 | -17.3% ▼ |
| Fluticasone propionate (Inhalation) | 365 | 462 | £11.4K | -5.7% ▼ |
| Thiamine hydrochloride | 354 | 18.9K | £496 | -32.8% ▼ |
| Estradiol | 353 | 23.6K | £3.1K | -57.0% ▼ |
| Betamethasone valerate | 335 | 31.1K | £2.0K | -13.0% ▼ |
| Hyoscine butylbromide | 325 | 27.6K | £2.1K | +39.5% ▲ |
| Topiramate | 322 | 24.8K | £1.4K | +81.2% ▲ |
| Insulin aspart | 322 | 1,855 | £11.4K | -15.4% ▼ |
| Buprenorphine | 321 | 4,164 | £5.2K | -12.4% ▼ |
| Codeine phosphate | 321 | 27.4K | £956 | -55.3% ▼ |
| Famotidine | 317 | 15.7K | £8.5K | -35.0% ▼ |
| Senna | 317 | 18.4K | £429 | -47.3% ▼ |
| Levetiracetam | 316 | 24.5K | £4.7K | -31.0% ▼ |
| Tiotropium bromide | 315 | 3,504 | £8.8K | +3.6% ▲ |
| Insulin glargine | 315 | 1,463 | £12.7K | +10.9% ▲ |
| Methylphenidate hydrochloride | 308 | 13.3K | £7.6K | +19.3% ▲ |
| Diltiazem hydrochloride | 307 | 17.0K | £2.7K | +0.0% vs avg |
| 304 | 39.9K | £2.6K | +40.5% ▲ | |
| Nitrofurantoin | 297 | 3,350 | £1.8K | -37.8% ▼ |
| 297 | 389 | £2.2K | +25.7% ▲ | |
| Esomeprazole | 295 | 15.6K | £1.6K | -27.1% ▼ |
| Mometasone furoate | 291 | 353 | £2.8K | -27.5% ▼ |
| Sitagliptin | 290 | 10.5K | £770 | -25.6% ▼ |
| Solifenacin | 290 | 9,076 | £354 | -39.2% ▼ |
| Glyceryl trinitrate | 289 | 491 | £671 | +22.2% ▲ |
| Cetirizine hydrochloride | 287 | 23.3K | £1.0K | -42.6% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.